The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

3.13%Dividend Yield

Dec 2025

$0.77

Dec 2024

$0.11

Dec 2023

$0.14

Dec 2022

$0.07

Dec 2021

$0.02

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

127.71%

1Y Growth

619.44%

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

ARK Genomic Revolution

ARKG

Mkt Cap0

ARK Genomic Revolution ETF focuses on companies likely to benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, genomics, and molecular diagnostics, directly competing with WDNA's biotech and genomic focus.

iShares Genomics Immunology and Healthcare

IDNA

Mkt Cap0

iShares Genomics Immunology and Healthcare ETF targets companies in genomics, immunology, and bioengineering, directly aligning with the biorevolution sector that WDNA invests in.

Global X Genomics & Biotechnology

GNOM

Mkt Cap0

Global X Genomics & Biotechnology ETF is designed to invest in companies involved in genomics and biotechnology, making it a direct competitor to WDNA which focuses on the bio-revolution industry.

Principal Healthcare Innovators Index

BTEC

Mkt Cap0

Principal Healthcare Innovators Index ETF focuses on growth companies in the healthcare sector, including biotechnology and genomics, competing in the same space as WDNA.

Virtus Biotech Clinical Trials

BBC

Mkt Cap0

Virtus LifeSci Biotech Clinical Trials ETF invests in companies with significant business in biotechnology clinical trials, overlapping with WDNA's investment in biotech innovation.

VanEck Biotech

BBH

Mkt Cap0

VanEck Biotech ETF invests in companies in the biotech sector, which is a key focus area for WDNA, making it a competitor.

Invesco Biotechnology & Genome

PBE

Mkt Cap0

Invesco Dynamic Biotechnology & Genome ETF focuses on biotech and genome companies, competing directly with WDNA's thematic investment approach.

First Trust NYSE Arca Biotechnology Index Fund

FBT

Mkt Cap0

First Trust NYSE Arca Biotechnology Index Fund is a competitor due to its investment in biotechnology companies, a sector that WDNA also targets.

State Street SPDR S&P Biotech

XBI

Mkt Cap0

SPDR S&P Biotech ETF offers exposure to the biotech sector, competing with WDNA which invests in biotech and genomic revolution companies.

iShares Biotechnology

IBB

Mkt Cap0

iShares Biotechnology ETF invests in U.S. biotechnology and pharmaceutical companies, making it a competitor to WDNA with its focus on the biotech sector.

Holdings

Regions

Sectors

About

This fund primarily aims to meet its investment goals by employing a representative sampling method. This means it selects a portion of the securities from its benchmark index, ensuring that this smaller selection closely reflects the broader index's risk profile, expected returns, and other key characteristics. The benchmark index itself is crafted to invest in global, exchange-listed companies that are poised for significant transformation through breakthroughs in genetic research and biotechnology. It's important to note that this fund is categorized as non-diversified.

CEO

ISIN

US97717Y6187

Listings

0 Comments

Share your thoughts

FAQs

What is WisdomTree BioRevolution Fund stock price today?▼

The current price of WDNA.BOATS is $24.60 USD — it has increased by +0% in the past 24 hours. Watch WisdomTree BioRevolution Fund stock price performance more closely on the chart.

What is WisdomTree BioRevolution Fund stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange WisdomTree BioRevolution Fund stocks are traded under the ticker WDNA.BOATS.

Does WisdomTree BioRevolution Fund pay dividends?▼

Yes, WDNA.BOATS dividends are paid annual. The last dividend per share was 0.77 . As of today, Dividend Yield (FWD)% is 3.13%.

In which sector is WisdomTree BioRevolution Fund located?▼

WisdomTree BioRevolution Fund operates in the Other sector.

When did WisdomTree BioRevolution Fund complete a stock split?▼

WisdomTree BioRevolution Fund has not had any recent stock splits.